Filing Flows › Utah Medical Products (UTMD) › Who owns the stock
Who owns Utah Medical Products (UTMD) stock
107 funds reported Utah Medical Products (UTMD) shares in their latest 13F filings, worth $166M in all. The largest holder is Brandes Investment Partners, LP ($32.8M). Last quarter 48 funds added to their stakes and 39 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Brandes Investment Partners, LP | 475,158 | $32.8M | increase | 2026-06-30 |
| BlackRock | 203,690 | $14.1M | increase | 2026-06-30 |
| Dimensional Fund Advisors LP | 198,817 | $13.7M | increase | 2026-06-30 |
| Renaissance Technologies LLC | 175,814 | $12.1M | decrease | 2026-06-30 |
| Vanguard Group | 175,971 | $9.8M | increase | 2025-12-31 |
| Vanguard Capital Management LLC | 134,535 | $9.3M | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 108,048 | $7.5M | decrease | 2026-06-30 |
| Minerva Advisors LLC | 93,615 | $6.5M | unchanged | 2026-06-30 |
| Hotchkis & Wiley Capital Management LLC | 85,231 | $5.9M | decrease | 2026-06-30 |
| Rice Hall James & Associates, LLC | 71,363 | $4.9M | increase | 2026-06-30 |
| Morgan Stanley | 69,671 | $4.8M | increase | 2026-06-30 |
| State Street | 63,937 | $4.4M | decrease | 2026-06-30 |
| Quantinno Capital Management LP | 43,074 | $3.0M | increase | 2026-06-30 |
| UBS Group AG | 34,369 | $2.4M | decrease | 2026-06-30 |
| Bank of New York Mellon | 34,263 | $2.4M | increase | 2026-06-30 |
Utah Medical Products' latest quarter
Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most UTMD stock?
By the latest 13F filings: Brandes Investment Partners, LP ($32.8M); BlackRock ($14.1M); Dimensional Fund Advisors LP ($13.7M); Renaissance Technologies LLC ($12.1M); Vanguard Group ($9.8M).
What is the short interest in UTMD?
140,215 shares were sold short at the 2026-10-15 settlement, -7.7% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.